David Giljohann

David Giljohann has a diverse work experience in the biotech industry. David is currently the Chief Executive Officer of EVOQ Therapeutics, starting in January 2023. Before that, they co-founded Exicure Inc. in December 2011 and served as the COO from June 2012 to September 2013. David continued to work at Exicure, Inc. as the CEO from September 2013 to December 2021. Prior to starting Exicure, Inc., David worked as a Principal Scientist at AuraSense, LLC from 2009 to 2011. Their career began as a student at Northwestern University in 1999, where they stayed until 2009.

David Giljohann attended Northwestern University for their education. It is not specified the exact start and end years or the specific field of study for their undergraduate degree. However, they pursued a Doctor of Philosophy (Ph.D.) degree at Northwestern University as well.